Palogic Value Management’s Intel INTC Stock Holding History

Palogic Value Management’s Portfolio INTC Stock Details INTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,225	Closed	-$244K	–	164
2022 Q4	$244K	Buy	+9,225	New	+$256K	0.13%	130

Other funds holding INTC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Palogic Value Management's INTC Position: Q1 2023 in Review

Palogic Value Management sold out of Intel (INTC) in Q1 2023, closing a stake of 9,225 shares — an estimated $244K sold.

Palogic Value Management first reported a position in INTC in Q4 2022 and held it in 1 quarter. The position peaked at $244K in Q4 2022. 2,412 funds tracked by Wall St. Rank hold INTC as of Q1 2023.

Palogic Value Management reported no remaining Intel position as of Q1 2023 after selling out during the quarter.
Palogic Value Management sold 9,225 Intel shares in Q1 2023, an estimated $244K.
Palogic Value Management first reported a position in Intel in Q4 2022 and held it in 1 quarter.
Palogic Value Management's Intel position peaked at $244K in Q4 2022.
2,412 funds tracked by Wall St. Rank held Intel as of Q1 2023.

Based on Palogic Value Management's 13F filing for Q1 2023, filed 12 May 2023.